CONMED Corp — Director's Dealing 2022

Apr 8, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-04-01

Reporting Person: Lalomia Brent (Vice President QA and RA)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	500	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options To Purchase Common Stock	$83.15	2029-06-17	Common Stock (2500)		Direct
Options To Purchase Common Stock	$97.69	2030-03-02	Common Stock (4000)		Direct
Options To Purchase Common Stock	$122.55	2031-03-01	Common Stock (4000)		Direct
Options To Purchase Common Stock	$144.55	2032-03-01	Common Stock (8000)		Direct

Footnotes

F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period